Business News • MarketWire • Vernalis Licenses V2006 to RedoxTherapies Inc for Use in Immuno-Oncology

Vernalis Licenses V2006 to RedoxTherapies Inc for Use in Immuno-Oncology

Vernalis Licenses V2006 to RedoxTherapies Inc for Use in Immuno-Oncology

WINNERSH, UNITED KINGDOM--(Marketwired - Oct 9, 2014) - Vernalis plc (LSE: VER) (PINKSHEETS: VNLPY)

View More : http://www.marketwired.com/mw/release.do?id=1956038&sourceType=3

Releted News by marketwire